Controlled diuretic monotherapy in hypertensive patients: Efficiency and metabolic safety
- 作者: Semenkin A1, Zhivilova L1, Nechaeva G1, Chindareva O1, Loginova E1, Pritykina T2
-
隶属关系:
- Омский государственный медицинский университет Минздрава России
- Клинико-диагностический центр «Ультрамед»
- 期: 卷 88, 编号 9 (2016)
- 页面: 59-64
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32072
- DOI: https://doi.org/10.17116/terarkh201688959-64
- ID: 32072
如何引用文章
全文:
详细
作者简介
A Semenkin
Омский государственный медицинский университет Минздрава РоссииОмск, Россия
L Zhivilova
Омский государственный медицинский университет Минздрава РоссииОмск, Россия
G Nechaeva
Омский государственный медицинский университет Минздрава РоссииОмск, Россия
O Chindareva
Омский государственный медицинский университет Минздрава РоссииОмск, Россия
E Loginova
Омский государственный медицинский университет Минздрава РоссииОмск, Россия
T Pritykina
Клинико-диагностический центр «Ультрамед»Омск, Россия
参考
- Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-2219. doi: 10.1093/eurheartj/eht151 2159-2219
- Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертония среди лиц 25—64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014;13(4):4-14. doi: 10.15829/1728-8800-2014-4-4-14
- Ram CV. Beta-blockers in hypertension. Am J Cardiol. 2010;106(12):1819-1825. doi: 10.1016/j.amjcard.2010.08.023
- Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies. Drug Saf. 2001;24(15):1155-1165. doi: 10.2165/00002018-200124150-00006
- Kuo SW, Hung YJ, Hsieh AT et al. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. Am J Hypertens. 2003;16(8):623-628. doi: 10.1016/S0895-7061(03)00896-3
- Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet. 1999;353(9169):2008-2013. doi: 10.1016/s0140-6736(98)07614-4
- Morgan TO, Anderson AI, MacInnis RJ. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens. 2001;14(3):241-247. doi: 10.1016/s0895-7061(00)01266-8
- Musini VM, Nazer M, Bassett K, Wright JM. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev. 2014;5:CD003824. doi: 10.1002/14651858.CD003824.pub2
- Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure? J Renin Angiotensin Aldosterone Syst. 2004;5(4):155-160. doi: 10.3317/jraas.2004.034
- Uehara Y, Shirahase H, Nagata T et al. Radical scavengers of indapamide in prostacyclin synthesis in rat smooth muscle cell. Hypertension. 1990;15(2):216-224. doi: 10.1161/01.hyp.15.2.216
- Gosse P, Sheridan DJ, Zannad F et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J Hypertens. 2000;18(10):1465-1475. doi: 10.1097/00004872-200018100-00015
- Marre M, Puig JG, Kokot F et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. J Hypertens. 2004;22(8):1613-1622. doi: 10.1097/01.hjh.0000133733.32125.09
- Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321:868-873. doi: 10.1056/nejm198909283211305
- Mantel-Teeuwisse AK, Kloosterman JM, Maitland-van der Zee AH et al. Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf. 2001;24:443-456. doi: 10.2165/00002018-200124060-00003
- Kris-Etherton PM, Pearson TA, Wan Y et al. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr. 1999;70:1009-1015. PMID: 10584045
- Kasim-Karakas SE, Almario RU, Mueller WM et al. Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake. Am J Clin Nutr. 2000;71:1439-1447. PMID: 10837283
- Barter P. HDL-C: role as a risk modifier. Atheroscler Suppl. 2011;12(3):267-270. doi: 10.1016/S1567-5688(11)70885-6.
- Eberly LE, Cohen JD, Prineas R, Yang L. Intervention Trial Research group. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care. 2003;26(3):848-854. doi: 10.2337/diacare.26.3.848
- Verdecchia P, Reboldi G, Angeli F et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension. 2004;43(5):963-969. doi: 10.1161/01.hyp.0000125726.92964.ab
- Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ. 2003;326(7391):681. doi: 10.1136/bmj.326.7391.681
- Семенкин А.А. Возможности использования показателей функции сосудистой стенки в качестве маркеров негативных метаболических эффектов лечения тиазидными диуретиками больных артериальной гипертонией. Терапевтический архив. 2007;79(4):31-38. PMID: 17564015